Pilot study of tolerability and safety of opioid receptor antagonists as novel therapies for chronic pain among persons living with HIV with past year heavy drinking: a randomized controlled trial

AIDS Care. 2023 Aug;35(8):1191-1200. doi: 10.1080/09540121.2021.1896663. Epub 2021 Mar 7.

Abstract

ClinicalTrials.gov identifier: NCT03278886.

Keywords: HIV; Pain; alcohol; nalmefene; naltrexone.

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Alcoholism*
  • Chronic Pain* / drug therapy
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Naltrexone / therapeutic use
  • Narcotic Antagonists / therapeutic use
  • Pilot Projects
  • Treatment Outcome

Substances

  • Narcotic Antagonists
  • Naltrexone

Associated data

  • ClinicalTrials.gov/NCT03278886